2.38 USD
+0.030.00%
盘后 2.37 -0.42%
2026-08-03
市值
$225.11M
市盈率
6.38
EPS
0.37
股息率
—
52 周区间
1.30 – 3.24
成交量
344.93K
Beta
2.78
目标价
4.60
52W 低 1.3052W 高 3.24
价格走势
公司简介
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company’s pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been evaluated for the treatment of solid tumors as a monotherapy and in combination of PVRIG/PD-1 and PVRIG/TIGIT, as well as PVRIG/PD-1/T...